|Application ||WB, E|
|Other Accession||NP_006524.1, 8190|
|Calculated MW||14509 Da|
|Other Names||Melanoma-derived growth regulatory protein, Melanoma inhibitory activity protein, MIA|
|Format||0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||MIA / CD-RAP Antibody (internal region) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Elicits growth inhibition on melanoma cells in vitro as well as some other neuroectodermal tumors, including gliomas.|
|Tissue Location||All malignant melanoma cell lines tested and infrequently in glioma cell lines|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The immunizing peptide represents the N terminus of the mature protein. Reported variants represent identical protein: NP_006524.1, NP_001189482.1,
Impact of lymph node metastases on serum level of melanoma inhibitory activity in stage III melanoma patients. Hofmann MA, Schicke B, Fritsch A, Biesold S, Gussmann F, Küchler I, Voit C, Trefzer U. J Dermatol. 2011 Sep;38(9):880-6. PMID: 21658116
If you have any additional inquiries please email technical services at email@example.com.